Scholars@Duke
construction release_alert
Profile editing will be unavailable for Scholars@Duke profiles from June 11-24, 2026 as manual profile data entry transitions to Elements. More information about the transition.
cancel
Sophia Cenac Weinmann

Sophia Cenac Weinmann

Associate Professor of Medicine
Medicine, Rheumatology and Immunology

Selected Publications

Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors.

Journal Article Rheumatology (Oxford) · December 1, 2019 Immune checkpoint inhibitors are novel biologic agents to treat cancer by inhibiting the regulatory interactions that limit T cell cytotoxicity to tumours. Current agents target either CTLA-4 or the PD-1/PD-L1 axis. Because checkpoints may also regulate au ... Full text Open Access Link to item Cite